- Home
- BNTX vs AEE Comparison
BNTX vs AEE Comparison
Compare BNTX & AEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNTX | AEE |
|---|---|---|
| Founded | 2008 | 1901 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 27.5B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTX | AEE |
|---|---|---|
| Price | $108.22 | $103.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $140.31 | $110.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 11-03-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.73% |
| EPS Growth | N/A | ★ 22.35 |
| EPS | N/A | ★ 5.21 |
| Revenue | $3,698,814,972.00 | ★ $8,635,000,000.00 |
| Revenue This Year | $2.03 | $14.77 |
| Revenue Next Year | N/A | $5.96 |
| P/E Ratio | ★ N/A | $19.97 |
| Revenue Growth | 3.70 | ★ 23.25 |
| 52 Week Low | $81.20 | $90.84 |
| 52 Week High | $126.77 | $106.73 |
Technical Indicators
Market Signals| Indicator | BNTX | AEE |
|---|---|---|
| Relative Strength Index (RSI) | 70.02 | 64.89 |
| Support Level | $105.16 | $99.71 |
| Resistance Level | $109.28 | $101.13 |
| Average True Range (ATR) | 2.35 | 1.57 |
| MACD | 1.52 | 0.55 |
| Stochastic Oscillator | 83.23 | 97.44 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and 800,000 natural gas customers across its two service territories.